Industry and Agency Support

2018 Foundation, Industry And Agency Support

We are proud to acknowledge the following for their contributions to and generous support of our program.

Premier




Angel

 

GHI_for_web_000

 

 Patron

Amgen
GlaxoSmithKline
Immunomedics

Major Supporter 

Abbvie/Pharmacylics
Bristol-Myers Squibb
NanoString Technologies
Puma Biotechnology, Inc.
TESARO

Contributors

Biotheranostics
Celgene Corporation
Daiichi Sankyo Inc.
H3 Biomedicine
Lumicell
MacroGenics, Inc.
Menarini Silicon Biosystems
Myriad Genetic Laboratories, Inc.
Natera
Odonate Therapeutics Inc.
Seattle Genetics
Spectrum Pharmaceuticals
Syndax Pharmaceuticals
Wolters Kluwer

Donors 

23andMe
Agendia
Ambry Genetics
Caris Life Sciences
Cepheid
Cianna Medical
Coherus BioSciences
Dignitana
Elsevier, Inc.
Epic Sciences
Faxitron
Helsinn Therapeutics US, Inc.
JAMA Network
Mitra Biotech
NeoGenomics Laboratories
The Oncologist
Paxman USA Inc.
Philips Molecular Pathway DX
PreludeDx
Radius Health, Inc.
RareCyte, Inc.
R-Pharma US
Springer Healthcare Education
Tempus
TerSera Therapeutics
Toray International America, Inc.
TRIO - Translational Research in Oncology
Zero Gravity Skin

  SABCS gratefully acknowledges the Breast Cancer Research Foundation for generous support of the AACR Outstanding Investigator Award for Breast Cancer Research.


This activity is supported by educational grants provided by AbbVie, AstraZeneca, Eisai, Lilly USA, LLC (for further information concerning Lilly grant funding, visit www.lillygrantoffice.com), Merck, Novartis, Pfizer and Tesaro.

 

 Funding for this conference was made possible (in part) by 1R13CA213939-03 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the US Government.